openPR Logo
Press release

Global Transcriptomics Technologies Market to be Driven by the Development of Bioinformatics Tools and Services

12-27-2016 03:17 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Global Transcriptomics Technologies Market to be Driven by

The report on the global transcriptomics technologies market bundles all factors that have influenced this market over the past few years and utilizes clear and effective processes and methodologies to ascertain the future of the global transcriptomics technologies market. The report states that the global transcriptomics technologies market is expected to expand handsomely over the next few years.

Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1659

The global transcriptomics technologies market is divided in terms of technology, applications, and geography. The report then quantifies the leading segments according to each criterion in order to simplify the evaluation process of the global transcriptomics technologies market. This involves defining all market drivers and restraints that propel and hinder the global transcriptomics technologies market, respectively.

The key driving factor of the global transcriptomics technologies market is the growing requirement for all products in the market for personalized healthcare and comparison diagnostics. Other driving factors for the global transcriptomics technologies market include the availability of sufficient gear in laboratories as well as healthcare organizations, along with an increasing awareness of the benefits that transcriptomics technologies can bring to the healthcare sector.

The report explains key aspects that could affect the global transcriptomics technologies market in the coming few years.

The report utilizes proven research methods such as SWOT analysis and Porter’s five forces analysis to update the report’s user with the global transcriptomics technologies market’s determinant macro and micro factors as well as the value chain.

The global transcriptomics technologies market is exhibiting a 15.90% CAGR from 2013 to 2019. The market was valued at US$1.65 bn in 2012. The consistent growth pattern of the market will lead to a value of US$4.6 bn for the global transcriptomics technologies market by the end of 2019.

The key segments of the global transcriptomics technologies market according to technology are gene regulation technologies, microarrays, PCR, and NGS. Transcriptomics technologies find major use in gene expression patterns and drug discovery. Transcriptomics technologies are also applied in the clinical diagnosis of central nervous system disorders, cardiovascular disorders, and cancers. Transcriptome analysis tools offer accurate insights into gene sequence identification, gene expression patterns, and gene regulation mechanisms.

The global transcriptomics technologies market could be restrained by factors such as the non-availability of resources and tools that help in analyzing critical and complex data, the lack of tools that allow for biology computation, and the overall lack of skilled manpower with domain expertise.

The global transcriptomics technologies market is led by Asia Pacific, which has the fastest growth rate, due to the sharply increasing population in the region, coupled with the consequent boost in supply by the vendor base in the region. North America is the largest regional segment of the global transcriptomics technologies market and held a revenue share of 35.0% in 2012.

Browse Research Report: http://www.transparencymarketresearch.com/transcriptomics-technologies-market.html

The top players in the global transcriptomics technologies market are Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina, Inc., and Life Technologies Corporation.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Transcriptomics Technologies Market to be Driven by the Development of Bioinformatics Tools and Services here

News-ID: 401859 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Transcriptomics

Transcriptomics Market Overall Study Report 2024-2031
Transcriptomics Market Trends Overview 2024-2031: A new Report by Coherent Market Insights, titled "Transcriptomics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Transcriptomics market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Transcriptomics
Spatial Genomics and Transcriptomics Market
Market Overview The market for spatial genomics and transcriptomics is anticipated to reach USD million by 2029, expanding at a compound annual growth rate (CAGR) of 9.35% from 2023 to 2030. Spatial genomics is a new field of molecular biology that aims to examine the genomic information of single cells in their natural tissue context, and spatial transcriptomics is a groundbreaking molecular profiling technology that enables scientists to map all gene
Transcriptomics Market - Unlocking the secrets of the genome: The booming transc …
Newark, New Castle, USA: The "Transcriptomics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Transcriptomics Market: https://www.growthplusreports.com/report/transcriptomics-market/7733 This latest report researches the industry structure, sales, revenue, price and
Spatial Genomics & Transcriptomics Market - Mapping the Secrets of Life: Spatial …
Newark, New Castle, USA: The "Spatial Genomics & Transcriptomics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Spatial Genomics & Transcriptomics Market: https://www.growthplusreports.com/report/spatial-genomics-transcriptomics-market/8507 This latest report researches the
Demand for Spatial Genomics & Transcriptomics Estimated to Reach US$2 Billion by …
The Global 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 & 𝐓𝐫𝐚𝐧𝐬𝐜𝐫𝐢𝐩𝐭𝐨𝐦𝐢𝐜𝐬 Market is estimated to attain a valuation of US$ 2 Billion by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 17% during the forecast period, 2023 - 2033. The key objective of the TMR report is to offer a complete assessment of the global market including
Transcriptomics Technologies Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Transcriptomics Technologies market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report reveals market